• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

WHO delivers insulin pens to Ukraine hospitals with support from Novo Nordisk

September 2, 2022 By Sean Whooley

World Health Organization WHO Insulin Pens Ukraine
[Image from WHO]
The World Health Organization (WHO) announced that it delivered more than 26 metric tonnes of insulin pens to Ukraine.

WHO distributed approximately 57,320 pounds of insulin pens (more than 370,000 total pens) to hospitals throughout Ukraine. It represents part of an effort to help those with diabetes in the country during the ongoing humanitarian crisis.

The organization said in a news release that estimates show more than 9% of Ukraine’s population is living with diabetes mellitus. It can cause costly and debilitating complications including heart attacks, strokes, kidney failure, blindness and lower-limb amputations if untreated. The delivery of insulin pens aims to help those people improve their quality of life.

Hospitals in the Dnipropetrovsk, Ivano-Frankivsk, Khmelnytskyi, Kirovohrad, Kyiv, Mykolaiv, Poltava, Rivne, Ternopil, Volyn, Zakarpattya and Zaporizhzhia regions are on the receiving ends of the effort by WHO. Donations were made possible with support from Novo Nordisk and the nongovernmental organization Direct Relief.

WHO said it is “making every effort” to provide vital insulin as soon as possible and in full to all patients, including children, who need the therapy. It said it needs a well-functioning logistics system to comply with the necessary storage and transport conditions, including cold chain.

“Access to insulin can save lives and prevent the development of disabling complications,” said Dr. Jarno Habicht, WHO Representative in Ukraine. “WHO is stepping up its efforts with the Ministry of Health to respond to mounting health needs throughout Ukraine. It is vital that access to insulin and other medicines is made available during these challenging times, as the coming months could test Ukraine’s health system as never before.”

Filed Under: Auto-injectors, Diabetes, Drug-Device Combinations, Featured Tagged With: Novo Nordisk, WHO, World Health Organization

IN CASE YOU MISSED IT

  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS